These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

622 related articles for article (PubMed ID: 25493013)

  • 41. Identification of microRNA-214 as a negative regulator of colorectal cancer liver metastasis by way of regulation of fibroblast growth factor receptor 1 expression.
    Chen DL; Wang ZQ; Zeng ZL; Wu WJ; Zhang DS; Luo HY; Wang F; Qiu MZ; Wang DS; Ren C; Wang FH; Chiao LJ; Pelicano H; Huang P; Li YH; Xu RH
    Hepatology; 2014 Aug; 60(2):598-609. PubMed ID: 24616020
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Emerging role of microRNA-21 in colorectal cancer.
    Zhao J; Zhang Y; Zhao G
    Cancer Biomark; 2015; 15(3):219-26. PubMed ID: 25769454
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MicroRNAs in colorectal cancer metastasis.
    de Krijger I; Mekenkamp LJ; Punt CJ; Nagtegaal ID
    J Pathol; 2011 Aug; 224(4):438-47. PubMed ID: 21706478
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Integrated regulatory mechanisms of miRNAs and targeted genes involved in colorectal cancer.
    Wang J; Yu H; Ye L; Jin L; Yu M; Lv Y
    Int J Clin Exp Pathol; 2015; 8(1):517-29. PubMed ID: 25755742
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of miRNA in transformation from normal tissue to colorectal adenoma and cancer.
    Liu G; Li B
    J Cancer Res Ther; 2019; 15(2):278-285. PubMed ID: 30964098
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Decreased Expression of MIR-134 and its Clinical Significance in Human Colorectal Cancer.
    Xie Y; Song J; Zong Q; Wang A; Yang Y; Liu F; Meng X
    Hepatogastroenterology; 2015 May; 62(139):615-9. PubMed ID: 26897940
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MicroRNA Expression in Formalin-fixed Paraffin-embedded Cancer Tissue: Identifying Reference MicroRNAs and Variability.
    Boisen MK; Dehlendorff C; Linnemann D; Schultz NA; Jensen BV; Høgdall EV; Johansen JS
    BMC Cancer; 2015 Dec; 15():1024. PubMed ID: 26714641
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MicroRNAs as Therapeutic Targets and Colorectal Cancer Therapeutics.
    Yamamoto H; Mori M
    Adv Exp Med Biol; 2016; 937():239-47. PubMed ID: 27573904
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MicroRNAs as Regulator of Signaling Networks in Metastatic Colon Cancer.
    Wang J; Du Y; Liu X; Cho WC; Yang Y
    Biomed Res Int; 2015; 2015():823620. PubMed ID: 26064956
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of colorectal cancer stem cell survival and invasive potential by hsa-miR-140-5p mediated suppression of Smad2 and autophagy.
    Zhai H; Fesler A; Ba Y; Wu S; Ju J
    Oncotarget; 2015 Aug; 6(23):19735-46. PubMed ID: 25980495
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Biomarkers for Stratification in Colorectal Cancer: MicroRNAs.
    Fadaka AO; Pretorius A; Klein A
    Cancer Control; 2019; 26(1):1073274819862784. PubMed ID: 31431043
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New trends in molecular and cellular biomarker discovery for colorectal cancer.
    Aghagolzadeh P; Radpour R
    World J Gastroenterol; 2016 Jul; 22(25):5678-93. PubMed ID: 27433083
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MicroRNAs as Regulators, Biomarkers and Therapeutic Targets in the Drug Resistance of Colorectal Cancer.
    Xie T; Huang M; Wang Y; Wang L; Chen C; Chu X
    Cell Physiol Biochem; 2016; 40(1-2):62-76. PubMed ID: 27842308
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Emerging microRNA biomarkers for colorectal cancer diagnosis and prognosis.
    Chen B; Xia Z; Deng YN; Yang Y; Zhang P; Zhu H; Xu N; Liang S
    Open Biol; 2019 Jan; 9(1):180212. PubMed ID: 30958116
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MicroRNA expression profiles in human colorectal cancers with liver metastases.
    Lin M; Chen W; Huang J; Gao H; Ye Y; Song Z; Shen X
    Oncol Rep; 2011 Mar; 25(3):739-47. PubMed ID: 21174058
    [TBL] [Abstract][Full Text] [Related]  

  • 56. microRNAs and Colorectal Cancer.
    Ress AL; Perakis S; Pichler M
    Adv Exp Med Biol; 2015; 889():89-103. PubMed ID: 26658998
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Colorectal cancer characterization and therapeutic target prediction based on microRNA expression profile.
    Xu P; Zhu Y; Sun B; Xiao Z
    Sci Rep; 2016 Feb; 6():20616. PubMed ID: 26852921
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Using Blood and Plasma MicroRNAs as a Non-Invasive Biomarker in Patients with Colorectal Cancer.
    Stefanescu H; Muntean D; Pilut C; Diaconu M; Popescu R; Hutanu D; Moise M; Diana L; Nitu R; Cherecheanu AP; Negoita S; Iovan CV; Ungureanu E; Calu V; Ciuca I
    Clin Lab; 2018 Mar; 64(3):257-262. PubMed ID: 29739108
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An update on microRNAs as colorectal cancer biomarkers: where are we and what's next?
    Okugawa Y; Toiyama Y; Goel A
    Expert Rev Mol Diagn; 2014 Nov; 14(8):999-1021. PubMed ID: 25163355
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MicroRNAs as potential investigative and predictive biomarkers in colorectal cancer.
    Yaghoubi N; Zahedi Avval F; Khazaei M; Aghaee-Bakhtiari SH
    Cell Signal; 2021 Apr; 80():109910. PubMed ID: 33387618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.